Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05512208 |
Title | A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib (DURAFAK) |
Acronym | DURAFAK |
Recruitment | Recruiting |
Gender | female |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | University of Oklahoma |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of New Mexico Comprehensive Cancer Center | RECRUITING | Albuquerque | New Mexico | 87131 | United States | Details |
Stephenson Cancer Center | RECRUITING | Oklahoma City | Oklahoma | 73117 | United States | Details |